Cocrystal Pharma, Inc. (COCP) vs Celyad SA (CYAD)

Cocrystal Pharma, Inc. and Celyad SA are both Biotechnology companies. Cocrystal Pharma, Inc. and Celyad SA are of similar size ($23.8M and $22.2M). Celyad SA has the higher net margin (0.00% vs −747.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Celyad SA leads on 8 and Cocrystal Pharma, Inc. on 5.

Valuation

Metric COCP CYAD Biotechnology median
P/E n/m n/m 7.88
P/S 12.14 n/m 11.47
P/B 15.45 11.18 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 10.46 n/m 10.73
Earnings yield (64.96%) (708.87%) (28.84%)
Free cash flow yield (49.38%) (438.06%) (23.03%)

Profitability

Metric COCP CYAD Biotechnology median
Gross margin 9.10% 0.00% 65.16%
Operating margin (760.72%) — 0.00%
Net margin (747.78%) 0.00% 0.00%
Free cash flow margin (598.50%) 0.00% 0.00%
Return on equity (311.68%) 0.00% (57.72%)
Return on assets (151.10%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric COCP CYAD Biotechnology median
Revenue growth (TTM) (30.38%) — 5.64%
EPS growth (last fiscal year) 54.65% 113.33% —
Revenue growth, 5-year CAGR (33.30%) (63.51%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COCP CYAD Biotechnology median
Debt to equity 0.00 (0.24) 0.00
Current ratio 1.24 0.66 4.73
Net debt to EBITDA 0.82 (1.62) 0.96

Dividend

Metric COCP CYAD Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric COCP CYAD Biotechnology median
Market cap 22.15m 23.79m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack